This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitè Laval. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Malika Laouedj: Innovator in Leukemia Treatment
Introduction
Malika Laouedj is a prominent inventor based in Québec, Canada. She has made significant contributions to the field of medical research, particularly in the treatment of leukemia. Her innovative work has the potential to impact the lives of many patients suffering from this disease.
Latest Patents
Malika Laouedj holds a patent for an anti-S100A8 protein designed for treating leukemia. This patent, which is a groundbreaking development, involves an anti-S100A8 antibody that specifically binds to a portion of the S100A8 protein and/or a S100A8/S100A9 heterodimer. This targeted approach aims to provide a more effective treatment option for leukemia patients.
Career Highlights
Laouedj is affiliated with Université Laval, where she conducts her research and develops her innovative treatments. Her work at this esteemed institution has allowed her to collaborate with other leading researchers in the field.
Collaborations
Some of her notable coworkers include Philippe A. Tessier and Frédéric Barabe. Their collaborative efforts contribute to the advancement of research in leukemia treatment and enhance the potential for successful outcomes.
Conclusion
Malika Laouedj is a trailblazer in the field of leukemia treatment, with her innovative patent showcasing her dedication to improving patient care. Her work at Université Laval and collaborations with esteemed colleagues further solidify her impact in the medical research community.